Keyphrases
Acne Vulgaris
100%
Adverse Events
93%
Tretinoin
75%
Benzoyl Peroxide
75%
Treatment Group
75%
Systemic Chemotherapy
75%
Onycholysis
75%
Acne Vulgaris Treatment
75%
Cleanser
75%
Weekly Paclitaxel
75%
Aging Neck
75%
Volume Loss
75%
Hand Rejuvenation
75%
Tazarotene
75%
Poly(L-lactic acid)
75%
Treatment Strategy
75%
Botulinum Neurotoxin (BoNT)
75%
Clinical Experience
75%
Monotherapy
56%
Patient Data
50%
Clinical Practice
50%
Combination Regimen
37%
Basic Pharmacology
37%
Traditional Techniques
37%
Product Selection
37%
Patient Selection
37%
Intense Light
25%
Chemical Peeling
25%
Ablative Resurfacing
25%
Pigment Laser
25%
Thermolysis
25%
Microdermabrasion
25%
Dry Climate
25%
Diverse Patient Population
25%
Asian Americans
25%
Number of Injections
25%
Nodule
25%
Aging Hand
25%
Frequency of Use
25%
Prescribing Practices
25%
Soft Tissue
25%
Light Source
25%
Laser Therapy
25%
Papules
25%
Latest Technology
25%
Serious Adverse Events
25%
Tissue Degeneration
25%
Laser Resurfacing
25%
African American Patients
25%
Skin Type
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
75%
Botulinum Toxin A
75%
Onycholysis
75%
Paclitaxel
75%
Benzoyl Peroxide
75%
Acne Vulgaris
75%
Monotherapy
75%
Retinoic Acid
75%
Microsphere
75%
Clostridium Botulinum Type A
75%
Skin Tightness
25%
Inflammation
25%
Tolerability
25%
Acne
25%
Clinical Trial
25%
Adverse Event
25%
Anthracycline
21%
Doxorubicin
21%
Taxane
21%
Ultraviolet Radiation
10%
Medicine and Dentistry
Tazarotene
75%
Acne Vulgaris
75%
Onycholysis
75%
Paclitaxel
75%
Adverse Event
75%
Rejuvenation
75%
Chemotherapy
75%
Polylactic Acid
56%
Patient-Data
37%
Skin Type
25%
Patient Population
25%
Adolescence
25%
Doxorubicin
21%
Anthracycline
21%
Chemexfoliation
18%
Low Level Laser Therapy
18%
Papule
18%
Injectable Filler
18%
Soft Tissue Augmentation
18%
Ultraviolet Radiation
10%